Sun Pharmaceutical Industries

太阳制药工业公司

has appointed

已任命

Kirti Ganorkar

基尔蒂·加诺尔卡

as the Managing Director to succeed

作为董事总经理继任

Dilip Shanghvi

稀释香格里拉

, effective September 1, with the entire business and all functions reporting to him, the company said in a press release on Friday. Ganorkar has been heading India business at Sun Pharma since June 2019.

，自 9 月 1 日起生效，整个业务和所有职能部门都将向他汇报。该公司在周五的新闻发布会上表示。自 2019 年 6 月以来，甘诺尔卡尔一直在领导太阳制药的印度业务。

This appointment is subject to approval of the shareholders at the upcoming annual general meeting, the release said.

该新闻稿称，此项任命还有待即将召开的年度股东大会上股东们的批准。

Shanghvi will continue as the Executive Chairman of the Board. He will focus on strengthening Sun Pharma’s

商维将继续担任董事会执行主席，他将专注于加强太阳制药的

specialty portfolio

专业作品集

and provide insights towards shaping company’s long-term strategy.

并为制定公司的长期战略提供见解。

Under Ganorkar’s leadership, the company’s India business has grown consistently, further increasing its market share.

在甘诺卡的领导下，公司印度业务持续增长，进一步提高了市场份额。

He has previously held various

他之前担任过各种职务

leadership roles

领导角色

across business development, marketing, M&A, new product introduction, project management, IP and litigation at Sun Pharma.

在太阳制药公司（Sun Pharma）从事商业开发、市场营销、并购、新产品引进、项目管理、知识产权及诉讼等工作。

Live Events

现场活动

Ganorkar played a key role in driving Sun Pharma’s foray into specialty by securing rights for innovative products such as Ilumya. He led Sun Pharma’s entry into Japan and laid initial groundwork for the company’s entry into Europe. He supported the US business with stewardship of several notable generic projects from concept to commercialisation..

甘诺卡在推动太阳制药进军 specialty 领域方面发挥了关键作用，确保了如 Ilumya 等创新产品的权利。他领导了太阳制药进入日本市场的进程，并为公司进入欧洲市场奠定了初步基础。他还通过从概念到商业化的多个重要仿制药项目，支持了美国业务的发展。

A chemical engineer and MBA, Ganorkar joined Sun Pharma in 1996.

甘诺卡于1996年加入太阳制药，他是一名化学工程师，也是工商管理硕士。

'Sun Pharma is at an exciting juncture with all its businesses well-positioned for growth. Building on the strong foundation laid by Mr Shanghvi and ably supported by our global leadership team, I’m confident of continued success of the company,” Kirti Ganorkar, Managing Director (Designate) of Sun Pharma stated in the press release..

“太阳制药正处于一个令人兴奋的时刻，其所有业务都为增长做好了充分准备。在Shanghvi先生奠定的坚实基础上，并得到我们全球领导团队的有力支持，我坚信公司将继续取得成功，”太阳制药总经理（指定）Kirti Ganorkar在新闻稿中表示。

Dilip Shanghvi, Chairman & Managing Director of Sun Pharma said: “Kirti has consistently demonstrated effective leadership managing diverse roles at Sun. I have a firm belief in his ability to lead the company into its next phase of growth and extend my best wishes for his success. Kirti’s elevation showcases our strong in-house talent pool, ensuring continuity of Sun’s core value systems.”.

太阳制药董事长兼董事总经理迪利普·桑赫维表示：“Kirti 在太阳制药担任多个不同职务期间，始终展现出卓越的领导能力。我坚信他能够带领公司进入下一个增长阶段，并祝愿他取得成功。Kirti 的晋升展示了我们强大的内部人才库，确保了太阳核心价值体系的延续。”

The company also said that

公司还表示

Abhay Gandhi

阿布哈伊·甘地

– President & CEO, North America, has decided to pursue his interests outside Sun Pharma.

– 北美地区总裁兼首席执行官决定在太阳制药之外追求自己的兴趣。

Richard Ascroft

理查德·阿斯克罗夫特

will be joining as CEO – North America, succeeding Gandhi. Ascroft is a seasoned biopharmaceutical executive with more than three decades of experience spanning commercial operations, market access, medical affairs, and corporate affairs across the U.S. and global markets. Most recently, he served as Senior Vice President and Business Unit Head of US plasma-derived therapies at Takeda Pharmaceuticals, and was a member of both the US and global executive leadership teams..

将接任北美首席执行官一职，接替甘地。阿斯克罗夫特是一位资深的生物制药高管，拥有三十多年的丰富经验，涵盖美国及全球市场的商业运营、市场准入、医学事务和企业事务。他最近的职务是武田制药美国血浆衍生疗法的高级副总裁兼业务部门负责人，并且是美国和全球执行领导团队的成员。

Aalok Shanghvi – Whole-time Director and Chief Operating Officer, has been additionally entrusted with the responsibility for the North America business wherein Ascroft will report to Aalok.

Aalok Shanghvi——全职董事兼首席运营官，还被额外赋予了负责北美业务的职责，其中Ascroft将向Aalok汇报工作。

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)